Aflibercept for Retinopathy of Prematurity - Intravitreal Injection Versus Laser Therapy

Clinical trial NCT04004208 · COMPLETED

Trial details

NCT number: NCT04004208
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Retinopathy of Prematurity (ROP)

Start date: 2019-09-25
Primary completion: 2021-02-12
Enrollment: 113

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.